NEWMeigu Barometer is live: an easy long-term strategy

Follow the big funds, skip the 13F wait.

A monthly list of the strong stocks big funds are buying, plus the Meigu Barometer after every US close: what to buy, and when to add or take cover.

Free to join · no credit card

  • List updated monthly
  • 100 buy signals this month
  • Barometer backtested since 2008
What is 13F?

A quarterly report showing what stocks big funds bought, sold, or held.

MeiguInsider is earlier

13F is delayed. Our monthly buy/sell reports help you spot where fund money is moving sooner.

NewMeigu Barometer · Institutional-grade market regime model

The macro call institutions make in-house, now open to retail investors.

Large institutions and hedge funds run internal macro market regime models to decide whether to buy in, add leverage or risk off. The Meigu Barometer opens up the results of this framework: five weather levels, updated after every US close, so retail investors can adjust their positions too.

Three institutional calls · the Bold version's position
Risk off
Storm, Rain
→ All cash
Buy in
Gentle Breeze
→ QQQ · 1x
Leverage
Sunny, Bright Sun
→ QLD · 2x

Updated after the Nov 18 close

Five levels

One reading for the whole backdrop

Each pillar is scored, the four are averaged, and the result becomes one of five levels of weather, from Storm to Bright Sun. The sunnier, the friendlier for US stocks.

  • Storm
  • Rain
  • Gentle Breeze
  • Sunny
  • Bright Sun
What's today's weather?
Sign up free to see the previous trading day's weather and four pillars, every day.
Unlock free
How to use it

Follow it in three steps

  1. 1
    Check the weather after the close

    Updated every US trading day at about 5:30pm ET, early next morning in Asia.

  2. 2
    Better weather, bigger position

    Bold switches between cash, QQQ (1x) and QLD (the 2x Nasdaq-100 ETF); Steady switches between cash and QQQ only.

  3. 3
    Trade only when the position changes

    Adjust at the next US open. That's about 31 times a year for Bold and 10 for Steady.

Bigger gains when it is time to add, smaller drawdowns when it is time to take cover

$10,000 invested on 2008-07-01, value on 2026-10-30
$809,000
4.5 times QQQ buy & hold ($177,850)
Annual return
27.1%
QQQ buy & hold: 17.0%
Max drawdown
−29.2%
QQQ buy & hold: −47.0%
Growth of $10,000 (log scale)
Bold (2x)QQQ buy & hold
$10k$30k$100k$300k$1.0M20102014201820222026$809k$177k

Hypothetical backtest, not a record of real trades; no trading costs or taxes. QLD is a daily-reset 2x leveraged ETF and swings about twice as much as QQQ. Past performance does not guarantee future results. For information and education only; not investment advice.

October recap

In October, the barometer spent most of the month in cash and sidestepped QQQ's fall.

October return
Bold
+0.0%
Steady
+0.0%
QQQ
−6.7%
SPY
−0.9%
  • 22 trading days: Gentle Breeze 4, Rain 10, Storm 8. In cash 18 days, invested 4 days. In cash from Oct 9 to the end of the month.
  • QQQ fell 9.1% from its high on Oct 6 to Oct 30; over the same days both versions returned −1.3%.
  • Year to date: Bold +15.3%, Steady +19.4%, QQQ +12.8%.

Public: last week's weather · Free members: the previous trading day · Pro: the same day after the close, with positions

Bold backtest: following one week late, the same $10,000 ended up about $327k smaller.

Free · No credit card · Updated after every US close

Want the same-day reading and position? Go Pro for under US$0.27 a day →
Current Report

This month's top 3

The list comes from our proprietary data on fund buying and selling: each month's strong stocks, each with a buy / hold / sell signal, a rank, 1/3/6-month performance and its industry. Here are the top 3.

Latest list: November 2026

OKTA
Okta, Inc.
+38.5%
last 3 months
Last close: $195.61
Sector: Technology
WING
Wingstop Inc.
+29.3%
last 3 months
Last close: $155.79
Sector: Consumer Cyclical
GKOS
Glaukos Corporation
+23.0%
last 3 months
Last close: $233.08
Sector: Healthcare
97 more buy signals

Pro members see this month's full list, rankings and the report archive; free members see reports 2 months later.

Looking back

The November Top 20 list, year to date

The 20 buy signals in the November list with the biggest gains this year, as an equal-weight basket with $10,000 from 2026-01-02, against SPY over the same period.

Data through the Nov 18 close

November Top 20 (equal weight)SPY
$10k$15k$20k$25k$30k2026-022026-042026-062026-082026-10$21.5k$10.7k

The 20 were picked for their gains this year as of the 2026-10-30 close, so this chart mostly looks back at them. It is not what following the list would have earned. Closing prices, without dividends or trading costs.

Industry Money FlowFree

Industry Money Flow

Tracks US industry ETF inflows, outflows, and short-term momentum shifts.

Open Full Industry Flow
Showing
2026-11-18
Tap a bubble to show or hide its trail · 2 selected
Accumulating
Leading
Lagging
Distributing
Data as of: 2026-11-18
Included Research Tool

AI Stock Analyst

Enter any US ticker and get a research report: price zones, catalysts, risks and an evidence score, with a source for every point.

Try the AI Stock Analyst

Full use with Pro; free members can try it a limited number of times.

Use it to dig into stocks you find in the monthly report.

Membership

Free Gets You In. Pro Gets You Earlier.

Start free with delayed reports. Upgrade for this month's report and the same-day barometer.

Free Member
$0

Delayed reports (2 months), this month's top 3 stocks and the previous day's Meigu Barometer.

Get Free Access
No credit card
Pro Member
Pro Member
$7.99/mo
Under US$0.27 a day · cancel anytime

One full list a month (100 buy signals with rankings this month), the report archive, the barometer and position after every US close, and unlimited AI Stock Analyst.

Upgrade to Pro
Cancel anytime. Secure checkout. Educational research only.
Compare plans
Compare plansFree MemberPro Member
Monthly strong-stock report2 months lateCurrent month
Tickers and rankingsTop 3 this monthFull list
Report archive
Meigu BarometerPrevious trading daySame day + daily position
AI Stock AnalystLimited
FAQ

Common Questions

Market Insights

Market Insights

View All
Nov 15, 2026GKOS

醫療創新三強的分水嶺: GKOS、MRNA、REGN 股價、現金流與預期的再檢驗

11月強勢股聚焦GKOS、MRNA與REGN,涵蓋眼科新品商業化、mRNA癌症疫苗與生物製藥。本文比較股價、財報、現金流及估值,辨識基本面支撐與預期風險。下月應追蹤GKOS新品銷售與保險給付、MRNA臨床申報與現金消耗、REGN藥品銷售及獲利;若財測下修、臨床延後或估值過熱,應檢視持有與追價風險。

Read more
Nov 9, 20262026年11月強勢股

MGID 2026年11月 前10名強勢股排名報告

2026 年 11 月美股強勢股排名顯示,醫療保健成為本期最具代表性的強勢族群。GKOS 受惠眼科創新產品商業化與財報成長,MRNA 憑藉疫苗核准及癌症療法臨床進展推動價值重估,REGN 則以多元藥品銷售與獲利成長展現基本面韌性。本期研究透過價格強度、趨勢品質、產業催化與基本面四大構面,篩選出前 10 名代表性強勢股,並分析其成長延續性、估值風險與下月關鍵追蹤指標。

Read more
Nov 1, 20262026年10月投資市場分析

2026年10月 月度投資市場分析報告

2026年10月市場在能源價格急升、通膨壓力回溫與AI資本支出疑慮下轉趨震盪。原油走強推升通膨與利率預期,科技股與高Beta資產則承受估值壓力。整體訊號偏弱且分化加劇,投資策略宜轉向中性偏防禦,保留部分現金、降低高波動部位,並提高高品質股票、黃金與防禦型資產配置。展望11月,Fed政策、油價、通膨與企業財測將是市場方向的重要驗證指標。

Read more

See our list and barometer free, then upgrade if they help

No credit card. Free members get reports 2 months later, this month's top 3 and the previous day's barometer.

No credit card · cancel Pro anytime